Navigation Links
Nuvelo Shareholders Approve Issuance of Common Stock Pursuant to Merger Agreement With ARCA biopharma
Date:1/7/2009

SAN CARLOS, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Nuvelo, Inc. (Nasdaq: NUVO) today announced that the stockholders of Nuvelo have approved the issuance of Nuvelo Common Stock pursuant to the merger agreement dated September 24, 2008, as amended, between Nuvelo, ARCA biopharma and a Nuvelo subsidiary. Nuvelo's stockholders also voted to adjourn Nuvelo's special stockholder meeting until January 23, 2009, to solicit additional proxies in favor of a proposal to amend the Company's amended and restated certificate of incorporation to effect a reverse stock split of the issued and outstanding shares of Nuvelo's common stock. This proposal is a necessary condition to the completion of the proposed merger.

A substantial majority of the proxies received by Nuvelo to date reflect votes cast in favor of both the proposal regarding the reverse stock split and a separate proposal to amend the Company's amended and restated certificate of incorporation to increase the number of authorized shares of Nuvelo common stock to 250 million. However, approval of each of these proposals requires the affirmative vote of a majority of the issued and outstanding shares of Nuvelo's common stock, which was not received by the time of the stockholder meeting. As the proposal relating to the stock split is a necessary condition to the completion of the proposed merger, while the proposal relating to the increase in authorized shares of Nuvelo common stock is not, the Board of Directors of Nuvelo has withdrawn the proposal to increase the number of authorized shares and the special stockholder meeting has been adjourned to a later date to solicit additional proxies on the proposal authorizing the reverse stock split.

The Nuvelo stockholder meeting will reconvene at 9:00 a.m. PST on January 23, 2009 at Nuvelo's corporate headquarters lo
'/>"/>

SOURCE Nuvelo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Nuvelo Reports First Quarter 2008 Financial Results and Updated Outlook for 2008
2. Nuvelo Reports Second Quarter 2008 Financial Results
3. Nuvelo Initiates Phase 1 Clinical Trial of NU206 in Healthy Volunteers
4. Nuvelo and ARCA biopharma Announce Merger Agreement Creating Late-Stage Cardiovascular Biotechnology Company
5. Nuvelo and ARCA biopharma Advance Toward Completion of Merger
6. Nuvelo Announces Positive Results from Phase 1 Clinical Trial of NU206 in Healthy Volunteers
7. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
8. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
9. Annual General Meeting ("AGM") and Extraordinary General Meeting ("EGM") Notices Posted to Shareholders
10. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
11. Pharmos Issues Letter to Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... (PRWEB) May 21, 2013 The Formulate ... display solution for sales and marketing teams looking for a ... describes the kit as “everything you’ll need to put together ... Display Kit comes with a number of displays and accessories ... booth 20 feet by 20 feet in size. These components ...
(Date:5/20/2013)... 20, 2013 Oven Industries Inc. announces ... capabilities. The 5R6-900 benchtop controller has many outstanding user-friendly ... be plugged into the wall as a self-contained temperature ... distinctive detail makes the device unique, as well as ... temperature controller can also be used universally, which allows ...
(Date:5/20/2013)...  Dr. Gerald Zon , noted ... launched a new blog in conjunction with TriLink BioTechnologies. ... focuses on what,s trending in the field of nucleic ... discussions of research presented at conferences and meetings, reviews ... Zon (PhD Princeton University 1971) developed automated synthesis of ...
(Date:5/20/2013)... , May 20, 2013 Cempra, ... on developing differentiated antibiotics to meet critical medical ... announced that it presented data at the American ... Philadelphia demonstrating the antibacterial and ... Cempra,s prior Phase 2 clinical trial in outpatients ...
Breaking Biology Technology:GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit 2New Laboratory Temperature Controller by Oven Industries 2Dr. Gerald 'Jerry' Zon Launches New Blog for TriLink BioTechnologies 2Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP) 2
... could be the basis of a new type of solar ... "We expect these structures will allow us to make better, ... investigator on the $100,000 grant. Fractals are patterns that ... silver 1-50th the width of a human hair are themselves ...
... American Botanical Council has announced that Bioforce AG is ... Investment in Phytomedicinal Research Award. Bioforce AG is a ... on pharmacological and clinical research each year, according to ... "We were surprised and honored to receive ...
... the difference between salt water and fresh water is ... ammonium bicarbonate salt solution, Penn State researchers can combine ... the salt-water fresh-water gradient to produce power anywhere. ... putting them together," said Bruce E. Logan, Kappe Professor ...
Cached Biology Technology:Bioforce Receives American Botanical Council's Tyler Award 2Bioforce Receives American Botanical Council's Tyler Award 3Bioforce Receives American Botanical Council's Tyler Award 4Bioforce Receives American Botanical Council's Tyler Award 5Unique salt allows energy production to move inland 2
(Date:5/17/2013)... Jersey, and City University of New York have invented ... effectively clears organisms to be viewed under microscopes. Visikol ... is one of the few high-quality clearing solutions currently ... Enforcement Administration (DEA) due to its use as a ... for viewing organisms under a microscope. Without them, microscope ...
(Date:5/17/2013)... Shenzhen, China---- Why Tibetan antelope can live at ... a collaborative research published in Nature Communications ... institutes provide evidence that some genetic factors may ... highland environments. The data in this work will ... and the biology of other ruminant species. , ...
(Date:5/17/2013)... American Societies for Experimental Biology (FASEB) released a new ... funding trends highlighting the devastating impact of sequestration on ... analysis follows a May 15th Senate Appropriations Committee hearing ... that the $1.6 billion cut the agency sustained in ... impact on the scientific community." , According to ...
Breaking Biology News(10 mins):New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2
... Leading experts from the European Society on Clinical ... and the International Osteoporosis Foundation (IOF) have published ... subtrochanteric femoral (upper thigh bone) fractures and long-term ... most common drug therapy for osteoporotic fracture prevention, ...
... a warmer world? UCLA life scientists present new evidence that ... polar bears lose habitat due to global warming, these biologists ... sources of food, where they will increasingly come into competition ... competition might unfold, the UCLA biologists constructed three-dimensional computer models ...
... This Thanksgiving, when you bite into the cranberry sauce and ... comment from your sister, consider the power of sour.,Neurobiology researchers ... discovery about how some cells respond to sour tastes. ... and umami sour is arguably the strongest yet the ...
Cached Biology News:IOF and ESCEO position on atypical femoral fractures and long-term bisphosphonate use 2Biologists report more bad news for polar bears 2Biologists report more bad news for polar bears 3Biologists report more bad news for polar bears 4Sour research, sweet results 2
... printer is portable, easy-to-use and makes identifying your ... Easy to use Labels withstand ... slide sizes Time/Date stamp ... Serialization feature makes you more efficient ...
... SPA Screening Assay, 5 x ... eliminate lengthy sample extraction procedures and ... 1.32-84.28 ng/ml (4-256 pmol/ml).Sensitivity: 0.65 ng/ml ... C. Category: Drug Screening & Cellular ...
The E. coli Expression System with Gateway Technology is designed to create E. coli expression clones containing the T7 promoter. The expression clones are ready for transformation and expression in ...
... C-1-tetrahydrofolate synthase, cytoplasmic ... Methylenetetrahydrofolate dehydrogenase (EC ... (EC 3.5.4.9); Formyltetrahydrofolate ... [Source:Uniprot/SWISSPROT;Acc:P11586] ...
Biology Products: